BocaGreenMD: Prena1 Generic Prescription Prenatal Vitamins

Published Online: Tuesday, July 23, 2013

Not All Generic Prescription Prenatals Are Created Equal

BocaGreenMD is a pharmaceutical company that specializes in providing generic pharmaceutical and nutritional health care products focused on improving the health, wellness, and quality of life for women of all ages.

BocaGreenMD’s Prena1 line of generic prescription prenatal vitamins contains a unique, proprietary blend of 1 mg of folate as 600 mcg of Quatrefolic®, the fourth-generation folate that bypasses MTHFR polymorphisms, and 400 mcg of folic acid:
  • Prena1 Plus, a comprehensive, daily dietary supplement, provides 16 vitamins and minerals per multivitamin tablet, plus 300 mg of DHA per softgel.
  • Prena1, a convenient, single daily softgel, contains essential vitamins, minerals, and 200 mg of DHA.
  • Prena1 Chew, a unique, vanilla-flavored, easy-to-chew tablet, dissolves quickly, making it ideal for women planning a pregnancy or who are pregnant and have difficulty swallowing tablets or capsules. Prena1 Chew includes vitamins B6 and B12 to help relieve nausea and morning sickness.

All Prena1 prenatal vitamins are gluten, lactose, sugar, and fish free.

Prena1, Prena1 Plus, and Prena1 Chew are available by prescription only at chain, independent, and mail order pharmacies throughout the United States. $15 rebate coupons for all 3 products are offered to patients at and at many pharmacies nationwide.

BocaGreenMD is a subsidiary of TherapeuticsMD, a specialty pharmaceutical company based in Boca Raton, Florida, that is focused on the sales, marketing, and development of branded and generic pharmaceutical and OTC products primarily for the women’s health care market.

For more information on BocaGreenMD and Prena1 prenatal vitamins, visit

For more information on TherapeuticsMD and its subsidiaries, visit

Latest Articles
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Latest Issues